Baldness, Benign Prostate Hyperplasia, Prostate Cancer, and Androgen Levels

January 2008 in “ The Aging Male ”

Gokhan Faydaci, Bilal Eryildirim, Penpegül Necmettin, Fatih Tarhan, Asuman Orçun, Uğur Kuyumcuoğlu

androgenic alopecia serum androgen levels Norwood's classification testosterone benign prostate hyperplasia prostate cancer AA BPH

TLDR The study found no link between baldness patterns and androgen levels in men with benign prostate enlargement or prostate cancer.

In the 2008 study involving 152 patients, with 108 diagnosed with benign prostate hyperplasia (BPH) and 44 with prostate cancer, researchers investigated the relationship between baldness patterns, specifically androgenic alopecia (AA), and serum androgen levels. They utilized Norwood's classification to categorize baldness into vertex and frontal types and measured serum total, free, and bioavailable testosterone, among other hormones. The study concluded that there was no significant difference in the prevalence of AA between the BPH and prostate cancer groups, nor was there a correlation between AA and serum androgen levels in either group. The researchers suggested the need for larger-scale studies to further explore the potential connections between BPH, prostate cancer, and AA.